SLC22A13

mutation — cross-omics
Cross-omicsMUTATION → RNACell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, SLC22A13 mutation is significantly associated with the RNA expression of many other genes, with 25 significant associations in total. CNS shows the largest number of these associations.

The most reproducible SLC22A13-associated genes across cancer lineages are ZPBP, TSPY2, and FAM205A. Each is linked with SLC22A13 in more than 1 cancer types. Because this analysis shows association rather than direction, both SLC22A13-to-partner and partner-to-SLC22A13 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, ZPBP grouped by SLC22A13-low versus SLC22A13-high in CNS.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (SLC22A13→partner) and Y-score (partner→SLC22A13) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CNSZPBP →+0.159+4.981<.001.00832
LARGE_INTESTINETSPY2 →+0.039+3.632<.001.00331
LARGE_INTESTINEFAM205A →+0.028+3.614<.001.00631
CNSIFNG →+0.043+5.321.003.00531
CNSPTH2 →+0.120+5.321<.001.00531
CNSASB10 →+0.062+4.981<.001.00831
Each partner links to its Q-omics profile. Showing the 6 strongest of 25 associations by consensus.

ZPBP by SLC22A13 expression — CNS

Box plot of ZPBP in SLC22A13-low vs SLC22A13-high samples in CNS.

Explore this box plot interactively →

Exploration